myocardial perfusion imaging in the pediatric population peter gardiner, mb chb, mrcp vice...
Post on 28-Dec-2015
212 Views
Preview:
TRANSCRIPT
Myocardial Perfusion Imaging in the Pediatric Population
Peter Gardiner, MB ChB, MRCP
Vice President, Medical Sciences
Bristol-Myers Squibb Medical Imaging
Bristol-Myers Squibb Medical Imaging• A worldwide leader in cardiovascular imaging
research• Product line includes:
– Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection)
– Definity® (Vial for Perflutren Lipid Microsphere Injectable Suspension)
• Committed to appropriate evaluation of imaging drugs and cardiac imaging procedures in children
• Focus on nuclear myocardial perfusion imaging (MPI)
Nuclear Myocardial Perfusion Imaging
• Only modality approved by FDA for assessment of myocardial perfusion and function
• >13 years experience with Tc99m agents• Indications: Perfusion; function; exercise and
pharmacologic stress• Extensive literature documenting use in diagnosis,
prognosis and risk stratification• Safe and well tolerated• Continued growth in usage
Cardiolite®(Kit for the Preparation of Technetium Tc99m Sestamibi for Injection)
• Launched in US in 1991• Indications: myocardial perfusion and function;
exercise and pharmacologic stress; developing information for use in patient management decisions
• Leadership position:– Clinical use
– Continued significant investment in Clinical Research and Education
Nuclear Myocardial Perfusion Imaging in Children
• Lack of substantial, well-controlled clinical studies to define dosing and efficacy
• Usage - ~ 2-3,000 studies in 2002• Patient populations:
– Kawasaki’s Disease
– Cardiac transplant vasculopathy
– Cardiomyopathies (including hypertrophic and drug-induced)
– Congenital heart disease, including anomalous LCA
Nuclear Myocardial Perfusion Imaging in Children
• Advantages– Extensive experience and FDA approved for use in
adults
– Operator independent
– Reduced dose and duration of imaging with Tc99m based agents
• Disadvantages– Radiation exposure
– Limited information on dosing (only weight-based)
– Lack of substantial efficacy data
Nuclear Myocardial Perfusion Imaging in Children
Summary
• Nuclear imaging is the only modality approved by FDA for assessment of myocardial perfusion and function in adults
• Extensive experience in adults• Limited and variable experience in children• Bristol-Myers Squibb Medical Imaging (BMS MI)
supports FDA’s initiatives to evaluate nuclear cardiac imaging in children
top related